4 recruiting, 1 unknown. 5 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Recruiting 4, Unknown 1 |
Follow Locally Advanced: new trials by email Literature Review of Locally Advanced trials Research Report on Locally Advanced
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC Medical device containing Y-90 microspheres delivered intratumorally and percutaneously into the pancreas - Pancreatic Ductal Adenocarcinoma (PDAC), Locally Advanced | Not applicable | Recruiting | BetaGlue Therapeutics SpA | 10 | 2026-02-03 | 2026-02-19 |
| Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy CTV omitted or delineated - Non Small Cell Lung Cancer, Locally Advanced | Not applicable | Recruiting | Hubei Cancer Hospital | 134 | 2024-02-08 | 2024-03-15 |
| Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer Stereotactic Ablative Body Radiation (SABR), Tumor Treating Fields (TTF) - Pancreas Cancer, Locally Advanced | Not applicable | Recruiting | Baptist Health South Florida | 48 | 2023-09-21 | 2026-01-12 |
| Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer Toripalimab, short-term radiotherapy, Oxaliplatin - Locally Advanced, High-Risk | Not applicable | Unknown | Nanfang Hospital, Southern Medical University | 53 | 2023-07-01 | 2023-07-05 |
| The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer Later-line therapy - Pancreatic Cancer, Locally Advanced | Not applicable | Recruiting | Peking Union Medical College Hospital | 100 | 2023-02-01 | 2023-04-12 |
Pancreatic Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Rectal Neoplasms (1)
Neoplasms (4) · Neoplasms by Site (4) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Pancreatic Diseases (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Colorectal Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Lung Diseases (1)
Capecitabine (1) · Oxaliplatin (1) · toripalimab (1)
Baptist Health South Florida (1) · BetaGlue Therapeutics SpA (1) · Hubei Cancer Hospital (1) · Nanfang Hospital, Southern Medical University (1) · Peking Union Medical College Hospital (1)
China (3) · Italy (1) · United Kingdom (1) · United States (1)
Chunmei Bai, MD (1) · Dehua Wu, MD (1) · Michael Chuong, M.D. (1)